BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9773856)

  • 1. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.
    De Geest S; Abraham I; Moons P; Vandeputte M; Van Cleemput J; Evers G; Daenen W; Vanhaecke J
    J Heart Lung Transplant; 1998 Sep; 17(9):854-63. PubMed ID: 9773856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.
    De Geest S; Borgermans L; Gemoets H; Abraham I; Vlaminck H; Evers G; Vanrenterghem Y
    Transplantation; 1995 Feb; 59(3):340-7. PubMed ID: 7871562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up.
    Dobbels F; De Geest S; van Cleemput J; Droogne W; Vanhaecke J
    J Heart Lung Transplant; 2004 Nov; 23(11):1245-51. PubMed ID: 15539122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication compliance after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene RA
    Transplantation; 1995 Nov; 60(9):914-20. PubMed ID: 7491693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to acute rejection in renal transplantation: the role of noncompliance.
    Morrissey PE; Reinert S; Yango A; Gautam A; Monaco A; Gohh R
    Transplant Proc; 2005 Jun; 37(5):2044-7. PubMed ID: 15964334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncompliance with immunnosuppressive medications after renal transplantation.
    Ghods AJ; Nasrollahzadeh D
    Exp Clin Transplant; 2003 Jun; 1(1):39-47. PubMed ID: 15859906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is noncompliance among adolescent renal transplant recipients inevitable?
    Feinstein S; Keich R; Becker-Cohen R; Rinat C; Schwartz SB; Frishberg Y
    Pediatrics; 2005 Apr; 115(4):969-73. PubMed ID: 15805372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
    J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical compliance and its predictors in the first year after heart transplantation.
    Dew MA; Roth LH; Thompson ME; Kormos RL; Griffith BP
    J Heart Lung Transplant; 1996 Jun; 15(6):631-45. PubMed ID: 8794030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonadherence is associated with late rejection in pediatric heart transplant recipients.
    Ringewald JM; Gidding SS; Crawford SE; Backer CL; Mavroudis C; Pahl E
    J Pediatr; 2001 Jul; 139(1):75-8. PubMed ID: 11445797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study.
    Girnita DM; Brooks MM; Webber SA; Burckart GJ; Ferrell R; Zdanowicz G; DeCroo S; Smith L; Chinnock R; Canter C; Addonizio L; Bernstein D; Kirklin JK; Ranganathan S; Naftel D; Girnita AL; Zeevi A
    Transplantation; 2008 Jun; 85(11):1632-9. PubMed ID: 18551071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.